In just a few years, molecular fingerprinting of Mycobacterium tuberculosis has provided clinicians with significant insight into the epidemiology of tuberculosis. This methodology has allowed for a new understanding of the extent of new transmission of tuberculosis among residents of various communities and within institutions. It has also allowed for differentiation between episodes of reinfection and relapse, a task hitherto almost impossible to accomplish. In addition, molecular fingerprinting has allowed assessment of situations where laboratory cross-contamination is suspected. Thus, this technology has in many ways made clinicians reexamine many of their long-held beliefs regarding tuberculosis. In this report, Drs. Behr and Small provide a lucid description of molecular fingerprinting of M. tuberculosis, its current uses, and its future potential value.
In the 5 years since the development of DNA-based fingertients receiving antituberculous therapy [16] and the development of drug resistant tuberculosis in patients coinfected with printing of Mycobacterium tuberculosis [1, 2] , nearly 100 articles have been published on the use of this methodology in HIV [17] . Although fingerprinting of M. tuberculosis is primarily pervarious epidemiological and clinical studies. In the public health domain, coordinated efforts involving conventional and formed in research facilities, fingerprinting is now available to all clinicians in the United States through the Centers for Dismolecular methods have shown foci of ongoing transmission in cities [3, 4] . The demonstration of transmission of M. tuberease Control and Prevention, and requests by clinicians for fingerprinting are becoming more frequent. In the present reculosis in nosocomial settings [5 -7] and congregate living facilities [8] and among persons at high risk such as the homeview we will briefly outline the techniques currently used in determining the molecular epidemiology of tuberculosis, deless [9, 10] and those who are HIV infected [6, 8] has been especially important. Fingerprinting in the context of geoscribe some of the limitations of these techniques, and describe examples of where such techniques can assist clinicians in the graphic studies has shown the acquisition of M. tuberculosis of Tunisian or Ethiopian genotypes by Dutch persons who treatment of patients with tuberculosis. For a more detailed bibliography on fingerprinting of M. tuberculosis, or for a listresided in Tunisia or Ethiopia [11] , as well as spread of the organism between Greenland and Denmark [12] .
ing of related activities in the field, the reader is referred to our World Wide Web home page and relevant links at: http// Instances of low-level transcontinental transmission have been observed within the United States [13] , while certain molepi.stanford.edu. strains of M. tuberculosis have been traced through interstate spread [14] . The results of laboratory studies based on molecular fingerprinting have highlighted the significant problem of Methods laboratory cross-contamination, with its attendant sequelae of
The most widely used methodology for fingerprinting M. infection-control costs and unnecessary therapy [15] . Observatuberculosis exploits restriction fragment length polymorphism tional studies have demonstrated exogenous reinfection of pa-(RFLP) of chromosomal DNA. A simplified illustration of the procedure is shown schematically in figure 1 . Simple endonuclease digestion of whole DNA, followed by electrophoretic separation (known as Restriction Enzyme Anal-807 CID 1997;25 (October) Molecular Epidemiology of Tuberculosis consensus as to the relative utility of the various secondary typing schemes. After blots are developed, the patterns obtained may be visually compared; however, if large numbers of patterns are generated, they are scanned into a computer database. This permits comparisons with previous fingerprints by using a combination of several human readers and computer assistance. The criteria for considering patterns to be ''matched'' vary between applications, with some requiring identity and others permitting some variability. Differences between patterns may represent genetic differences or artifacts that result from varying gel conditions and hybridization efficiency. The two principal types of genetic difference that can be observed involve change in the number of hybridization fragments (representing the number of IS6110 copies in an isolate) and their size (representing the length of the restriction fragments containing IS6110). Since a single mutation can modify the distribution of restriction sites, it is possible through one molecular event to alter the number and size of bands. Artifactual changes may result when two bands are so close together that they appear as one wide band or when a band is so faint because of poor hybridization that it is imperceptible. verged before the respective patients became infected and that the similarity is therefore a manifestation of shared history withSouthern blotting of electrophoretically-separated DNA and hybridize this DNA with probes to determine the presence and out direct transmission. Conversely, it may be that genetic change of the organism occurred during the process of transmission, and size of fragments containing specific DNA sequences. Repetitive elements called insertion sequences (ISs) are present in thus isolates with simple differences could represent temporally proximate transmission. In support of this possibility, subtle variable sites and copy numbers, allowing comparison of the number and size of fragments containing an IS. The most comchanges have occasionally been detected over time in strains isolated from chronically infected patients [20] . monly used IS is IS6110, which is found throughout the M. tuberculosis complex, usually in 5 -20 copies at various positions
The rapidity of pattern change (the molecular clock) is unclear but appears to vary according to the technique used (e.g., probing in the chromosome. Bacteria with fewer copies, including Mycobacterium bovis and M. bovis BCG, often cannot be discrimifor IS6110 vs. PGRS); the impression is that IS6110 is less stable [18] . Consequently, the epidemiological interpretation of similar nated with use of IS6110 alone and require secondary typing procedures such as blotting for polymorphic GC (guanine-cytofingerprints remains controversial; some investigators define transmission on the basis of identical fingerprints [3, 4] , while sine)-rich sequences (PGRS) [18] or the use of IS1081 or direct repeat (DR) sequences for identification. The selection of such others accept limited changes such as single band additions, deletions, and shifts [5, 10] . secondary typing techniques is somewhat controversial, and although PGRS is used in many laboratories for isolates with
The limitations of this methodology include the existence of strains with very low numbers of copies or no copies of IS6110 fewer than six copies of IS6110, at this time there is little / 9c3d$$oc41 [21], the labor involved in Southern blotting, and the attendant Laboratory cross-contamination. Episodes of laboratory cross-contamination by M. tuberculosis have been delineated difficulties of blot interpretation. In addition, the requirement for with the assistance of IS6110 genotyping, both in the context abundant growth of M. tuberculosis has led to the development of traditional mycobacteriology and radiometric systems of PCR-based typing [22] , which has been useful in instances [15] . It is believed that the sampling needles used in autowhere DNA from nonviable isolates could still be typed [23] . mated machines are the source of contamination; however, it has also been demonstrated that during conventional decontamination of specimens, there can be splashing and Indications transfer of organisms from the mucolytic solution [25] . The probability of obtaining useful information with fingerWhen a patient is reported to be culture positive for M. printing of M. tuberculosis, as with any laboratory test, is a tuberculosis but the clinical data are not consistent with function of the a priori suspicion of a positive result. In the the diagnosis, the clinician may suspect laboratory crosscontext of a tight geographic and temporal cluster, fingerprints contamination from another patient's sample. The first step will clearly demonstrate whether cases were part of the epiin evaluating this possibility is to determine whether the demic. When isolates of less-defined epidemiology are studied, patient's acid-fast smear was negative and whether any other similarities may be observed [24] , but the implication of these M. tuberculosis isolates were processed during the same pesimilarities in ongoing transmission is less certain.
riod at the same laboratory; if other isolates were processed, At present, the indications for M. tuberculosis fingerprinting they can be typed to determine whether there was possible include the situations described below, but as new questions in vitro cross-contamination. arise and the technology improves, other scenarios will likely Fingerprinting would also be useful in the event that an unexpected number of cultures are found to be positive for present themselves. (a pseudo-outbreak) .
Exogenous reinfection. A patient previously treated for [28] . In countries where childhood vaccination is routine, disseminated BCG infection has been described in children with M. tuberculosis infection who presents with a second episode of tuberculosis may have relapsed because of inadequate therimmunosuppression due to severe combined immunodeficiency, chronic granulomatous disease, complete DiGeorge apy or may represent exogenous reinfection. IS6110 blotting of the past and present isolates will determine whether a new syndrome, and AIDS [29] . Since commercial probes used in diagnostic microbiology laboratories are unable to identify strain is responsible for the second presentation. Therapy for the second infection will be governed by the results of antimi-M. tuberculosis complex isolates to the species level, IS1081 blotting of an isolate, typically along with the BCG strain of crobial susceptibility studies, but knowledge that a patient has been newly infected should alert clinicians and public health interest, has been performed to definitively identify the isolate as BCG [30] . officials to reevaluate the case (e.g., for the presence of risk factors such as HIV infection) and to perform an additional Diagnosis of M. bovis infections has typically not been as difficult; however, situations arise where an isolate has features source investigation.
Furthermore, given that tuberculosis treatment trials have that are not typical of either M. bovis or M. tuberculosis [31] . Fingerprinting with use of IS6110, as well as other probes, has generally been performed in high-prevalence areas, it is likely that ongoing transmission at these sites occurred, and some helped clarify the identity of such strains, showing whether they were acquired from cows or from wild animals [32], or cases classified as relapse may have been reinfection. Investigators conducting current efficacy trials use genotyping of subseeven occupationally, as in the case of seal handlers [33] . quent isolates to differentiate relapse from reinfection [26] .
Investigating the source of infection. Where a transmission link is epidemiologically suspected (e.g., among health care workConclusion ers [27]), it may be possible to obtain the suspected source patient's culture and perform genotyping of both isolates to demon-A century since Koch's discovery of the tubercle bacillus and a half century since the advent of effective chemotherapy, strate transmission. In settings where an ongoing surveillance project exists (e.g., San Francisco), the fingerprint of the new the white plague has not abated; this disease still causes an estimated 3 million deaths per year. Molecular typing of isolate can be immediately matched to an existent fingerprint database that contains all local isolates of M. tuberculosis. In this M. tuberculosis is a new, exciting, and powerful tool in the armamentarium of tuberculosis epidemiology whose ultimate manner, it may be possible to determine if the acquisition was due to occupational exposure or unrelated transmission.
contribution is still unclear. It is conceivable that the ability to identify and track individual clones of M. tuberculosis may When an unusual number of cases of tuberculosis occurs over time (e.g., during an institutional outbreak), it is possible ultimately provide important insights into pathogenesis and novel disease-control strategies. However, for now, clinical to do fingerprinting early on in the investigation to determine whether this cluster represents temporal coincidence or a cluster applications of this tool are relatively limited, and genotyping of clinical isolates outside a defined research protocol should due to transmission. In this situation, if fingerprinting demonstrates different strains, the cases are not due to transmission, be considered only in select instances. These instances include suspected laboratory cross-contamination, differentiation of reand there is no need for further epidemiological evaluation.
Changes in antimicrobial susceptibility. When multiple isolapse from exogenous reinfection, clarification of the cause of a change in drug susceptibility, recognition of disseminated lates of M. tuberculosis with varying antimicrobial susceptibilities are recovered from a single patient, acquired drug resistance, BCG disease, and corroboration of suspected transmission. The treatment and control of tuberculosis is a dynamically reinfection, or a laboratory error may be involved. The acquisition of drug resistance, especially in HIV-positive patients, has been changing endeavor, and thus the full utility of fingerprinting of M. tuberculosis isolates, integrated with conventional methods, demonstrated to occur without change in a strain's fingerprint [17] . Conversely, a patient may be reinfected with a new strain remains to be seen. With the ongoing contribution of clinicians and the specific scenarios they present, the fingerprinting of [16] or harbor more than one strain (author's unpublished data), which could also result in a variable antibiogram. Clinicians faced M. tuberculosis, together with other clinical information, may realize a greater role in the clinical management of tuberculosis. with the issue of acquired drug resistance should consider therapeutic issues such as drug malabsorption and the use of directly In addition, the public health role of this tool in gauging the efficiency of control programs is an exciting prospect whose observed therapy. New infection, on the other hand, would indicate the need for a source investigation. contribution remains to be determined.
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